Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04578249 · ClinicalTrials.gov registry record · NA
Effects of Blocking Blue Light At Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH
A NA study of Circadian Rhythm Disorders, sponsored by West Virginia University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04578249: Recruiting NA study of Circadian Rhythm Disorders, sponsored by West Virginia University.
NCT04578249 is a NA study of Circadian Rhythm Disorders that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 80 participants, below the 107-participant average among 7 other Circadian Rhythm Disorders trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04578249, a NA study of Circadian Rhythm Disorders, is actively recruiting participants, sponsored by West Virginia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose The purpose of this study is to determine whether filtering out blue light at nighttime reduces post-surgical inflammation and/or moderates cognitive decline and mood and sleep alterations in patients undergoing elective CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery. If manipulating nighttime light in hospital rooms improves patient outcomes, then it would be a relatively easy and inexpensive innovation that could reduce post-surgical complications and save millions of dollars per year in health care costs by shortening the length of hospital stays and reducing morbidity. The investigators aim to determine the relationship between inflammation and cognitive dysfunction after cardiac surgery.
Primary Outcome
Assessed via an immuno multiplex panel for the following cytokines:TNF-α, IL-1β, IL-6, IL-2, and IL-8. Units of measure for all cytokines are pg/mL.
Conditions Studied
Interventions
- OTHER Blue light-blocking goggles
- OTHER Clear goggles
Study Locations (1)
West Virginia
- West Virginia University Heart and Vascular Institute - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT04578249 shows while recruiting
NCT04578249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 107-participant average among 7 other Circadian Rhythm Disorders trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Circadian Rhythm Disorders appearing as the primary indexed condition, and to 2 interventions - of which Blue light-blocking goggles is the first listed.
NCT04578249 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT04578249 about?
NCT04578249 is a clinical study titled "Effects of Blocking Blue Light At Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH". Purpose The purpose of this study is to determine whether filtering out blue light at nighttime reduces post-surgical inflammation and/or moderates cognitive decline and mood and sleep alterations in patients undergoing elective CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery. If manipulating nig...
What is the current status of trial NCT04578249?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-09-20. Estimated completion is 2026-03.
What conditions does trial NCT04578249 study?
This clinical trial studies the following conditions: Circadian Rhythm Disorders.
What interventions are being tested in trial NCT04578249?
The interventions under investigation include: Blue light-blocking goggles (OTHER), Clear goggles (OTHER).
Who is sponsoring clinical trial NCT04578249?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04578249 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Circadian Rhythm Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mind After Midnight
RECRUITING · NA
-
The Effects of Bright Light Exposure on ICU Nurses
COMPLETED · NA
-
Systematic Light Exposure for Fatigue in Breast Cancer Patients
COMPLETED · NA
-
Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue
COMPLETED · NA
-
Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients
COMPLETED · NA
-
The Role of the Circadian System in Binge Eating Disorder
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI